Novartis Q2 2024 Adj EPS $1.97 Beats $1.89 Estimate, Sales $12.512B Beat $12.375B Estimate
Portfolio Pulse from Benzinga Newsdesk
Novartis (NYSE:NVS) reported Q2 2024 earnings of $1.97 per share, beating the analyst estimate of $1.89. Sales were $12.512 billion, surpassing the $12.375 billion estimate. Both earnings and sales showed significant year-over-year growth.
July 18, 2024 | 5:20 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Novartis reported Q2 2024 earnings of $1.97 per share, beating the analyst estimate of $1.89. Sales were $12.512 billion, surpassing the $12.375 billion estimate. Both earnings and sales showed significant year-over-year growth.
The earnings and sales figures both exceeded analyst expectations and showed significant year-over-year growth, which is likely to positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100